Shetzline Michael Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$1.59M

Insider Activity of Shetzline Michael

According to the SEC Form 4 filings, Shetzline Michael, being in a position of

  1. SVP, CMO, Head-Res&Drug at Ironwood Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 32582 shares for $121,586,
    over all time since 2021-02-26, has bought 0 shares, and sold 203595 shares for $1.71M.

Biography of Shetzline Michael

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$121,5862100

Comparison of Insiders on Amount of Buys and Sells

2026-02-24SaleIronwood Pharmaceuticals, Inc.
IRWD
SVP, CMO, Head-Res&Drug
17,012
0.0101%
$3.66$62,264+1.85%
2026-02-23SaleIronwood Pharmaceuticals, Inc.
IRWD
SVP, CMO, Head-Res&Drug
15,570
0.0097%
$3.81$59,322+2.8%
2025-02-10SaleIronwood Pharmaceuticals, Inc.
IRWD
SVP, CMO, Head-Res&Drug
41,269
0.0264%
$1.76$72,633-19.21%
2024-05-20SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
16,128
0.0102%
$6.45$104,026-36.6%
2024-02-12SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
38,618
0.0244%
$15.24$588,538-67.21%
2023-05-22SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
10,324
0.0062%
$10.12$104,479-10.23%
2023-02-28SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
9,854
0.0064%
$11.31$111,449-6.57%
2023-02-27SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
9,468
0.0062%
$11.41$108,030-7.22%
2022-05-23SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
7,453
0.0049%
$11.50$85,710-0.88%
2022-02-28SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
17,607
0.0112%
$10.77$189,627+7.25%
2021-11-23SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO,SVP,Head-Res&Drug
13,776
0.0085%
$11.58$159,526-1.76%
2021-05-24SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO, SVP & Head of Drug Devt.
2,077
0.0013%
$12.25$25,443-0.57%
2021-02-26SaleIronwood Pharmaceuticals, Inc.
IRWD
CMO, SVP & Head of Drug Devt.
4,439
0.0027%
$9.11$40,439+27.14%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.